Today, hundreds of drugs intended to treat a wide range of diseases have been approved by the FDA without critical evidence demonstrating they work. According to the database created for this ...

Last year the FDA paused multiple trials of RSV shots following cases of severe RSV in a study run by Moderna. One vaccine, Pfizer’s Abrysvo, is available for pregnant women and can pass RSV ...

Nieraj Jain was puzzled by the patient sitting quietly in front of him. The woman, in her 60s, was losing her eyesight; that much was clear. Her vision was blurred, and she was having increasing ...

FDA Approved — And Ineffective: Database Explainer BACKGROUND AND RATIONALE: Recent scandals about drugs like Aduhelm and Relyvrio have led to concerns about the U.S. Food and Drug Administration’s ...

The U.S. FDA approved 20 drugs for market in April, slightly down from 22 in March, 16 in February and 12 in January. This brings the total number of FDA approvals for the first four months of 2025 to ...

The U.S. Food and Drug Administration (FDA) has cleared marketing for a new blood test to diagnose Alzheimer's disease in people who are already exhibiting symptoms.

It was approved by the FDA in 2017 to treat obesity in people 12 and older. The most common side effects of liraglutide are nausea, vomiting, constipation, diarrhea, headache, fatigue, dyspepsia ...

Mounjaro and Zepbound Mounjaro and Zepbound are drugs known as tirzepatide. Mounjaro was approved in 2017 to treat Type 2 diabetes, while Zepbound was approved in more recent years to treat obesity.

Here are the eight FDA-approved weight loss medications: Ozempic and Wegovy Semaglutide, the active ingredient in Ozempic and Wegovy, mimics a natural hormone called GLP-1, according to WebMD. It ...

The FDA approved three natural food colorings - Galdieria extract blue, butterfly pea flower extract, and calcium phosphate - as alternatives following the ban on using artificial dyes.

However, two new drugs approved by the Food and Drug Administration could offer hope to those in the early stages. 10 On Your Side spoke with Norman Colpitts, 75, who has been on one of these new ...

The approval, which follows FDA Priority Review designation, offers a new treatment option in a proven class with the potential for lasting disease control in the broadest population of people living ...